Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-02-08

FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Dimethyl Fumarate from Glenmark Pharmaceuticals Inc., USA, typically resulting in label or packaging updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl fumarate (Dimethyl fumarate)

Snippet

SUPPL AP for DIMETHYL FUMARATE (DIMETHYL-FUMARATE)